Health Care & Life Sciences » Pharmaceuticals | Flexion Therapeutics Inc.

Flexion Therapeutics Inc. | Ownership

Companies that own Flexion Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Gilder, Gagnon, Howe & Co. LLC
3,450,547
9.13%
-248,695
0.8%
06/30/2018
Capital Research & Management Co. (World Investors)
2,872,000
7.6%
0
0.01%
06/30/2018
Miller Value Partners LLC
2,653,775
7.02%
-16,125
2.04%
06/30/2018
BlackRock Fund Advisors
2,617,724
6.92%
176,884
0%
06/30/2018
SSgA Funds Management, Inc.
2,034,958
5.38%
-286,680
0%
06/30/2018
Rubric Capital Management LP
1,973,714
5.22%
-49,990
4.49%
06/30/2018
Wells Capital Management, Inc.
1,711,024
4.53%
241,908
0.05%
06/30/2018
The Dreyfus Corp.
1,671,893
4.42%
97,539
0.09%
06/30/2018
The Vanguard Group, Inc.
1,518,753
4.01%
45,469
0%
06/30/2018
Pictet Asset Management SA
1,231,056
3.26%
-38,402
0.04%
06/30/2018

About Flexion Therapeutics

View Profile
Address
10 Mall Road
Burlington Massachusetts 01803
United States
Employees -
Website http://www.flexiontherapeutics.com
Updated 07/08/2019
Flexion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. The firm specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand.